Back to Screener
SYRE

Spyre Therapeutics, Inc.

SYRENASDAQ🇺🇸

Healthcare · Biotechnology

$43.06 2.03%

Last updated: 19h ago

52-Week Range

$10.91
$45.76

Company Overview

Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases. The company develops SPY001, a humanized monoclonal immunoglobulin G1 antibody that is in phase-2 clinical stage desi

Valuation

PER (TTM)
Forward PER-13.29
PBR5.58
PSR
EV/EBITDA
Market Cap$3.38B

Profitability

ROE-25.17%
ROA-19.80%
Net Margin0.00%
Operating Margin0.00%

Growth & Stability

Revenue Growth
Earnings Growth
Debt-to-Equity
Current Ratio13.25
Beta3.12

Dividends

Dividend Yield
Payout Ratio0.0%

Trading Info

Prev Close$43.95
Volume774K
Avg Volume725K
Employees102